Results 171 to 180 of about 12,760 (216)

Comparative analysis of two immunosuppression protocols for vulvovaginal candidiasis induction in Wistar rats. [PDF]

Braz J Microbiol
Munieweg FR, Ribeiro TP, Boldori JR, Rodrigues NR, Hoesel NLCS, Polleto ALR, Stopiglia CDO, Haas SE, Denardin CC.   +8 more
europepmc   +1 more source

Evaluation of epidemiological, clinical, and microbiological features of vulvovaginal candidiasis.

GMS Hyg Infect Control
Faraji R, Maleki A, Gheisoori A, Rashidi T, Salimi Mansouri A, Rashidi F, Faraji S, Kashefizadeh A, Bozorgomid A.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recurrent vulvovaginal candidiasis

Annals of Epidemiology, 2017
Recurrent vulvovaginal candidiasis (RVVC), multiple episodes of vulvovaginal candidiasis (VVC; vaginal yeast infection) within a 12-month period, adversely affects quality of life, mental health, and sexual activity. Diagnosis is not straightforward, as VVC is defined by the combination of often nonspecific vaginal symptoms and the presence of yeast ...
Freida Blostein, Elizabeth Levin-Sparenberg, Betsy Foxman   +2 more
exaly   +3 more sources

Biofilms and vulvovaginal candidiasis

Colloids and Surfaces B: Biointerfaces, 2019
Candida species, including C. albicans, are part of the mucosal flora of most healthy women, and inhabit the gastrointestinal and genitourinary tracts. Under favourable conditions, they can colonize the vulvovaginal mucosa, giving rise to symptomatic vulvovaginal candidiasis (VVC). The mechanism by which Candida spp.
Carmen Rodriguez-Cerdeira, Alberto Molares-Vila, Gabriella Fabbrocini   +2 more
exaly   +4 more sources

Recurrent vulvovaginal candidiasis

BMJ, 2020
### What you need to know A 22 year old woman asks your advice for treating recurrent thrush. She has self managed with over-the-counter treatments eight times in the past six months. She is frustrated and wants to know why it keeps coming back. Recurrent vulvovaginal candidiasis (RVVC) is a common problem, with an estimated prevalence of 9% in ...
Annabel, Lines, Inna, Vardi-Flynn, Clare, Searle   +2 more
openaire   +2 more sources

Vulvovaginal Candidiasis in Pregnancy

Current Infectious Disease Reports, 2015
Prevalence studies indicate that Candida species colonize the vagina in at least 20 % of all women, rising to 30 % in pregnancy. Although, some studies concluded that pregnant women were more likely to have symptomatic vaginal infections caused by Candida, yet other studies found a high prevalence of asymptomatic infection only during pregnancy.
T J, Aguin, J D, Sobel
openaire   +2 more sources

Vulvovaginal candidiasis

InnovAiT: Education and inspiration for general practice, 2013
Vulvovaginal candidiasis is a common condition that will, at some point, affect three-quarters of all women of reproductive age. It is caused by an overgrowth of Candida yeast. There are a number of situations that make candidiasis more likely, including pregnancy, diabetes, immunosuppression and use of antibiotics.
Adam Brocklebank, Hemant Maraj
openaire   +1 more source

Ibrexafungerp in the Treatment of Vulvovaginal Candidiasis

Annals of Pharmacotherapy, 2022
Objective To review the pharmacology, efficacy, and safety of ibrexafungerp in the management of vulvovaginal candidiasis (VVC). Data Sources Literature was sought using PubMed (1966—February 2022) and EMBASE (1973—February 2022), and ...
Kylie N. Barnes, Abigail M. Yancey, Alicia B. Forinash   +2 more
openaire   +2 more sources